ETFMG Adds Biotech to Thematic ETF Lineup with GERM

ETFMG, a leading thematic ETF issuer, announced today the launch of its latest innovative ETF, the ETFMG Treatments, Testing, and Advancements ETF (NYSE Arca: GERM). GERM seeks to answer investor demand for direct exposure to the biotech companies directly engaged in the testing and treatments of...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.